Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Correction of Anaemia With Darbepoetin Alfa at Monthly Dose Frequency in EU and Australian Patients With Chronic Kidney Disease Not on Dialysis

NCT02185911 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02185911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02185911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Correction of Anaemia With Darbepoetin Alfa at Monthly Dose Frequency in EU and Australian Patients With Chronic Kidney Disease Not on Dialysis
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
April 30, 2015
Enrollment
308 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia, chronic kidney disease (ckd)